These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26300426)

  • 1. Umbilical cord blood-derived dendritic cells infected by adenovirus for SP17 expression induce antigen-specific cytotoxic T cells against NSCLC cells.
    Liu Y; Tian X; Jiang S; Ren X; Liu F; Yang J; Chen Y; Jiang Y
    Cell Immunol; 2015; 298(1-2):18-24. PubMed ID: 26300426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calreticulin acts as an adjuvant to promote dendritic cell maturation and enhances antigen-specific cytotoxic T lymphocyte responses against non-small cell lung cancer cells.
    Liu X; Li J; Liu Y; Ding J; Tong Z; Liu Y; Zhou Y; Liu Y
    Cell Immunol; 2016 Feb; 300():46-53. PubMed ID: 26702740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel antigens in non-small cell lung cancer: SP17, AKAP4, and PTTG1 are potential immunotherapeutic targets.
    Mirandola L; Figueroa JA; Phan TT; Grizzi F; Kim M; Rahman RL; Jenkins MR; Cobos E; Jumper C; Alalawi R; Chiriva-Internati M
    Oncotarget; 2015 Feb; 6(5):2812-26. PubMed ID: 25739119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant mammaglobin A adenovirus-infected dendritic cells induce mammaglobin A-specific CD8+ cytotoxic T lymphocytes against breast cancer cells in vitro.
    Cui H; Zhang W; Hu W; Liu K; Wang T; Ma N; Liu X; Liu Y; Jiang Y
    PLoS One; 2013; 8(5):e63055. PubMed ID: 23650543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-prostate cancer effects of CTL cell induction in vitro by recombinant adenovirus mediated PSMA/4-1BBL dendritic cells: an immunotherapy study.
    Sui CG; Wu D; Meng FD; Yang MH; Jiang YH
    Genet Mol Res; 2015 Jun; 14(2):7208-17. PubMed ID: 26125931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful generation of sperm protein 17 (Sp17)-specific cytotoxic T lymphocytes from normal donors: implication for tumour-specific adoptive immunotherapy following allogeneic stem cell transplantation for Sp17-positive multiple myeloma.
    Chiriva-Internati M; Wang Z; Salati E; Wroblewski D; Lim SH
    Scand J Immunol; 2002 Oct; 56(4):429-33. PubMed ID: 12234264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor vaccine for ovarian carcinoma targeting sperm protein 17.
    Chiriva-Internati M; Wang Z; Salati E; Timmins P; Lim SH
    Cancer; 2002 May; 94(9):2447-53. PubMed ID: 12015770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dendritic cell-based tumour vaccine for lung cancer: full-length XAGE-1b protein-pulsed dendritic cells induce specific cytotoxic T lymphocytes in vitro.
    Zhou Q; Guo AL; Xu CR; An SJ; Wang Z; Yang SQ; Wu YL
    Clin Exp Immunol; 2008 Sep; 153(3):392-400. PubMed ID: 18803763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of cytotoxic T lymphocytes against human cancer cell lines using dendritic cell-tumor cell hybrids generated by a newly developed electrofusion technique.
    Imura K; Ueda Y; Hayashi T; Itoh T; Shimizu K; Tamai H; Yano Y; Naito K; Kohara J; Nakane K; Matsuura Y; Takeda A; Takeda T; Kawai K; Yamagishi H
    Int J Oncol; 2006 Sep; 29(3):531-9. PubMed ID: 16865268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sperm protein 17 (Sp17) in multiple myeloma: opportunity for myeloma-specific donor T cell infusion to enhance graft-versus-myeloma effect without increasing graft-versus-host disease risk.
    Chiriva-Internati M; Wang Z; Xue Y; Bumm K; Hahn AB; Lim SH
    Eur J Immunol; 2001 Aug; 31(8):2277-83. PubMed ID: 11477539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo induction of anti-leukemia cytotoxic T cell effect by dendritic cells from human umbilical cord blood cell origin.
    Tan H; Zeng LJ; Ye X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):472-8. PubMed ID: 15972145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antitumor effect of human cord blood-derived dendritic cells modified by the livin α gene in lung cancer cell lines.
    Chen H; Jin Y; Chen T; Zhang M; Ma W; Xiong X; Tao X
    Oncol Rep; 2013 Feb; 29(2):619-27. PubMed ID: 23152000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
    Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
    Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient generation of autologous peripheral blood-derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80-adenovirus together with interleukin 12 and interleukin 2.
    Mogi S; Ebata T; Setoguchi Y; Fujime M; Heike Y; Kohsaka T; Yagita H; Okumura K; Azuma M
    Clin Cancer Res; 1998 Mar; 4(3):713-20. PubMed ID: 9533541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sperm protein 17 (Sp17) is a suitable target for immunotherapy of multiple myeloma.
    Chiriva-Internati M; Wang Z; Salati E; Bumm K; Barlogie B; Lim SH
    Blood; 2002 Aug; 100(3):961-5. PubMed ID: 12130509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Generation of T cell-mediated antitumor response in vitro by autologous dendritic cells pulsed with tumor lysates in patients with non-small cell lung cancer].
    You J; Yu JP; Ren XB; Wang CL; Zhang P; Zhang XZ
    Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):333-6. PubMed ID: 15312341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer.
    Groeper C; Gambazzi F; Zajac P; Bubendorf L; Adamina M; Rosenthal R; Zerkowski HR; Heberer M; Spagnoli GC
    Int J Cancer; 2007 Jan; 120(2):337-43. PubMed ID: 17066423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Umbilical cord blood-derived CD11c(+) dendritic cells could serve as an alternative allogeneic source of dendritic cells for cancer immunotherapy.
    Kumar J; Kale V; Limaye L
    Stem Cell Res Ther; 2015 Sep; 6():184. PubMed ID: 26407613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumor immunity against nasopharyngeal carcinoma by means of LMP2A-specific cytotoxic T lymphocytes induced by dendritic cells.
    Xu JJ; Yao K; Yu CJ; Chen X; Lu MP; Sun H; Li BZ; Ding CN; Zhou F
    Auris Nasus Larynx; 2006 Dec; 33(4):441-6. PubMed ID: 16934422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD11c+ blood dendritic cells induce antigen-specific cytotoxic T lymphocytes with similar efficiency compared to monocyte-derived dendritic cells despite higher levels of MHC class I expression.
    Radford KJ; Turtle CJ; Kassianos AJ; Hart DN
    J Immunother; 2006; 29(6):596-605. PubMed ID: 17063122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.